PlGF expression in pre-invasive and invasive lesions of uterine cervix is associated with angiogenesis and lymphangiogenesis

APMIS

Volumn 117, Issue 11, 2009, Pages 831-838

  Yang, Shouhua ^a   Cheng, Henghui ^a   Cai, Jing ^a   Cai, Liqiong ^a   Zhang, Jing ^a   Wang, Zehua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiogenesis; Lymphangiogenesis; Placental growth factor; Uterine cervical cancer

Indexed keywords

PLACENTAL GROWTH FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; CARCINOMA IN SITU; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; UTERINE CERVICAL NEOPLASMS;

EID: 70350338637     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02538.x     Document Type: Article

References (32)

1. Rasila KK, Burger RA, Smith H, Lee FC, Verschraegen C. Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. Int J Gynecol Cancer 2005 15 : 710 726.
2. Cao Y. Opinion: emerging mechanisms of tumor lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005 5 : 735 743.
3. Van Trappen PO, Steele D, Lowe DG, Baithun S, Beasley N, Thiele W, et al. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis. J Pathol 2003 201 : 544 554.
4. Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer 2007 96 : 1092 1100.
5. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 2004 94 : 664 670.
6. Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 2002 1 : 99 108.
7. Orre M, Lotfi-Miri M, Mamers P, Rogers PA. Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary. Br J Cancer 1998 77 : 2204 2209.
8. Roskoski R Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 2007 62 : 179 213.
9. De Falco S, Gigante B, Persico MG. Structure and function of placental growth factor. Trends Cardiovasc Med 2002 12 : 241 246.
10. Schomber T, Kopfstein L, Djonov V, Albrecht I, Baeriswyl V, Strittmatter K, et al. Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis. Cancer Res 2007 67 : 10840 10848.
11. Nomura M, Yamagishi S, Harada S, Yamashima T, Yamashima T, Yamamoto H. Placental growth factor (PIGF) mRNA expression in brain tumor. J Neurooncol 1998 40 : 123 130.
12. Takahashi A, Sasaki H, Kim SJ, Kakizoe T, Miyao N, sugimura T, et al. Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. Biochem Biophys Res Commun 1999 257 : 855 859.
13. Woo LS, Prak MJ, Byun JH, Hong YS, Lee KS, Park YS, et al. Expression of placental growth factor gene in lung cancer. Tumour Biol 2004 25 : 1 6.
14. Parr C, Watkins G, Boulton M, Cai J, Jiang WG. Placental growth factor is over-expressed and prognostic value in human breast cancer. Eur J Cancer 2005 41 : 2819 2827.
15. Chen CN, Heieh FJ, Cheng YM, Cheng WF, Su YN, Chang KJ, et al. The significance of placental growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett 2004 213 : 73 82.
16. Kodama J, Seki N, Tokumo K, Nakanishi Y, Yoshinouchi M, Kudo T. Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma. Eur J Gynaecol Oncol 1997 18 : 508 510.
17. Ozalp S, Yalcin OT, Oner U, Tanir HM, Acikalin M, Sarac I. Microvessel density as a prognostic factor in pre-invasive and invasive cervical lesions. Eur J Gynaecol Oncol 2003 24 : 425 428.
18. Baluk P, McDonald DM. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann N Y Acad Sci 2008 1131 : 1 12.
19. Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, et al. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clin Cancer Res 2005 11 : 7637 7642.
20. Gao P, Zhou GY, Yin G, Liu Y, Liu ZY, Zhang J, et al. Lymphatic vessel density as a prognostic indicator for patients with stage I cervical carcinoma. Hum Pathol 2006 37 : 719 725.
21. Longatto-Filho A, Pinheiro C, Pereira SM, Etlinger D, Moreira MA, Jubé LF, et al. Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix. Gynecol Oncol 2007 107 : 45 51.
22. Näyhä V, Stenbäck F. Angiogenesis and expression of angiogenic agents in uterine and ovarian carcinosarcomas. APMIS 2008 116 : 107 117.
23. Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis 2007 38 : 258 268.
24. Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, et al. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 2007 131 : 463 475.
25. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001 7 : 186 191.
26. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001 7 : 192 198.
27. Achen MG, Stacker SA. Tumor lymphangiogenesis and metastatic spread - new players begin to emerge. Int J Cancer 2006 119 : 1755 1760.
28. Gombos Z, Xu X, Chu CS, Zhang PJ, Acs G. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 2005 11 : 8364 8371.
29. Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003 9 : 669 676.
30. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005 201 : 1089 1099.
31. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004 113 : 1040 1050.
32. Hong YK, Lange-Asschenfeldt B, Velasco P, Hirakawa S, Kunstfeld R, Brown LF, et al. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J 2004 18 : 1111 1113.